Esperance Pharmaceuticals

Esperance Pharmaceuticals

Esperance Pharmaceuticals

Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.
Raised
$40M
Follow us
Alexa global traffic share
Latest funding
$40,000,000
Venture capital (Series C) - 2016
Team Size
10+
Employees
$40,000,000 Venture capital (Series C)
Xconomy

Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push

Health Science Funding